UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Constellation Pharmaceuticals is implementing good security practices.
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.
This report shows a preliminary security rating for Constellation Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
A whaling attack is a type of phishing attack that targets high-level executives, such as the CEO ...
NIST Special Publication 800-53, Recommended Security Controls for Federal Information Systems and ...
Compare Constellation Pharmaceuticals's security performance with other companies